FUJIAN GENOHOPE BIOTECH LTD

Overview

FUJIAN GENOHOPE BIOTECH LTD is an active pharmaceutical ingredient (API) supplier with 8 active FDA Type II Drug Master Files, covering ORFORGLIPRON; PREFILLED SYRINGE OF STERILE WATER FOR INJECTION, 1 ML, USP; RETATRUTIDE; SEMAGLUTIDE; SEMAGLUTIDE (PROCESS II); SEMAGLUTIDE (PROCESS III).

API / Drug Master Files

FUJIAN GENOHOPE BIOTECH LTD holds 8 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SEMAGLUTIDE (PROCESS III)Active2025-09-30
• ORFORGLIPRONActive2025-09-16
• RETATRUTIDEActive2025-08-28
• PREFILLED SYRINGE OF STERILE WATER FOR INJECTION, 1 ML, USPActive2025-05-20
• SEMAGLUTIDE (PROCESS II)Active2024-12-09
• TIRZEPATIDEActive2024-09-19
• SEMAGLUTIDEActive2024-05-16
• SEMAGLUTIDEActive2024-03-07

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FUJIAN GENOHOPE BIOTECH LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.